Schweizerische Akademie der Pharmazeutischen Wissenschaften (SAPhW)

Demnächst

29/05/2015

  • Steven Taub, Research and Development Manager, Cardiovascular Surgery Department, Centre Hospitalier Universitaire Vaudois, CHUV,  Lausanne.
  • "Biotherapeutic Immunomodulation as a Countermeasure to  Hyperinflammatory Tissue Damage - A Double-Blind, Phase 1 Human Study of Osteoarthritis, with Surprising Efficacy".
  • Zusammenfassung (EN): may2015_taub_summary.pdf

26/06/2015

  • Prof. Dr. Oliver Germershaus, FHNW:
  • "Biomaterial Engineering meets Drug Delivery: Elektrogesponnene Kompositsysteme für die Freigabe makromolekularer Wirkstoffe"